Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire

Research Platform " Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire "

Set-up of a biobank for patients with an estimated date of infection seroconverters: store plasma and cells samples at initial contact and during follow-up for future analysis and analysis in international collaborative cohort seroconverters.

Inclusion Criteria:

• patients included in the last Primo-CI ANRS 1220 protocol
• All HIV infected individuals diagnosed during a blood donation with an estimated date of HIV seroconversion that will respect the following criteria: (i) age ≥18 (ii) HIV-1 or HIV-1+2 infected, (iii) HIV-seronegative at the preceding donation; (iv) who returned to the clinic to be informed of their HIV test result (v) with an HIV serology confirmed with two specific tests in two different laboratories (vi) who have never received ART for curative purpose
• informed on study objectives and have a signed informed consent.

Exclusion Criteria:

• Patient living outside of Abidjan